Zobrazeno 1 - 10
of 289
pro vyhledávání: '"metabolically unhealthy obesity"'
Autor:
Yahya Pasdar, Maryam Sharifi, Amir Saber, Davood Soleimani, Shima Moradi, Sahar Cheshmeh, Shahab Rezaeian, Farid Najafi
Publikováno v:
Eating and Weight Disorders, Vol 29, Iss 1, Pp 1-9 (2024)
Abstract Purpose The potential dietary inflammatory index (DII) and the phenomenon of obesity have been linked in recent studies, but it is unclear whether this connection is dependent on metabolic status. Therefore, it was thought that this research
Externí odkaz:
https://doaj.org/article/6bb72d23218b4d5584b2099ece1f4997
Autor:
Holubkina Ye.O., Tykhonova T.M.
Publikováno v:
Journal of V. N. Karazin Kharkiv National University: Series Medicine, Vol 32, Iss 2(49), Pp 238-255 (2024)
Background. Obesity occupies one of the leading places in the structure of non-communicable diseases and according to modern views it is a trigger factor for the occurrence of concomitant pathology, in particular, osteoarthritis. The driving force in
Externí odkaz:
https://doaj.org/article/a68d7e7165be4718bf41f464ed77a981
Autor:
A.O. Nikulina
Publikováno v:
Medičnì Perspektivi, Vol 29, Iss 1, Pp 108-114 (2024)
Obesity-induced dysregulation of hypothalamic neurons is not completely eliminated by restoring body weight, therefore the most urgent task of modern precision medicine is to predict the trajectory of development of metabolic disorders associated wit
Externí odkaz:
https://doaj.org/article/b55b726e5ebf4e0cb89b921a93f0d45e
Publikováno v:
Obesity Pillars, Vol 11, Iss , Pp 100114- (2024)
Background: The obesity paradox in patients with coronary artery disease is well established, but the role of the metabolic syndrome associated with obesity is not well studied. Our study aims to evaluate the in-hospital outcomes of percutaneous coro
Externí odkaz:
https://doaj.org/article/ec4a963a31774263a97daf8c5fac07ce
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundObesity represents a significant risk factor for the development of metabolic abnormalities. However, it is not inevitable that all individuals with obesity will develop these disorders. Selenium has been demonstrated to play a role in main
Externí odkaz:
https://doaj.org/article/0c7fc07186b34fc68d87562b92f6279b
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity, Vol Volume 17, Pp 1069-1079 (2024)
Hao Zhan,1,2 Qichun Chen,1,2 Tiantian Liu,1,2 Yuting Shi,1,2 Jinxia Pei,1,2 Liwei Zou,1,2 Longsheng Wang1,2 1Department of Radiology, the Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, People’s Republic of China; 2Medical Im
Externí odkaz:
https://doaj.org/article/00ed1b8a78d44fbf81ef1689421d26f9
Autor:
Oleksandr Abaturov, Anna Nikulina
Publikováno v:
Portuguese Journal of Pediatrics, Vol 55, Iss 2 (2024)
Introduction and Objectives: Single nucleotide variants (SNVs) of the gene associated with fat mass and obesity (FTO) make a significant contribution to the violation of energy metabolism and the development of obesity. Study the associations between
Externí odkaz:
https://doaj.org/article/40f97b1c67274704971c55c1b2182597
Autor:
Shiori Kawai, Hajime Yamakage, Kazuhiko Kotani, Mitsuhiko Noda, Noriko Satoh-Asahara, Koshi Hashimoto
Publikováno v:
Endocrine Journal, Vol 70, Iss 12, Pp 1175-1186 (2023)
Metabolically Healthy Obesity (MHO) is generally recognized as the absence of any metabolic disorders and cardiovascular diseases, including type 2 diabetes, dyslipidemia, and hypertension, in obese individuals; however, it is not clearly defined. Th
Externí odkaz:
https://doaj.org/article/bcf5f6d6ecfe493ab0dad968242882ea
Autor:
Baowen Yu, Moran Hu, Wanzi Jiang, Yizhe Ma, Jingya Ye, Qinyi Wu, Wen Guo, Yan Sun, Min Zhou, Yiwen Xu, Zhoulu Wu, Yiwen Wang, Sin Man Lam, Guanghou Shui, Jingyu Gu, John Zhong Li, Zhenzhen Fu, Yingyun Gong, Hongwen Zhou
Publikováno v:
Lipids in Health and Disease, Vol 22, Iss 1, Pp 1-12 (2023)
Abstract Background The criteria for metabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUO) remain controversial. This research aimed to identify a potential biomarker to differentiate the subtypes of obesity. Methods The study
Externí odkaz:
https://doaj.org/article/7d149b9f1a674d979bb8807053c0269d
Publikováno v:
Metabolites, Vol 14, Iss 9, p 502 (2024)
The factors determining the reversal of metabolically unhealthy obesity (MUO) to metabolically healthy obesity (MHO) after Roux-en-Y gastric bypass (RYGB) are not completely elucidated. The present study aims to evaluate body adiposity and distributi
Externí odkaz:
https://doaj.org/article/33af4deb521b4a8bb82bce6ef5b04d1e